Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Moloughney

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Recent Patents on Biotechnology|October 25, 2012
Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applicationsJoseph G Moloughney, Noah Weisleder
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Metallo-beta-lactamase inhibitors: promise for the future?Jeffrey H Toney, Joseph G Moloughney
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Old drugs resurrected?Janice D Thomas, Joseph G Moloughney, Jeffrey H Toney
FEMS Microbiology Letters|January 26, 2005
Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1Joseph G Moloughney, Janice D Thomas, Jeffrey H Toney
Plos One|November 28, 2012
Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscleXiaoli Zhao, Joseph G Moloughney, Sai Zhang, et al.
Autophagy|October 26, 2011
Vaccinia virus leads to ATG12–ATG3 conjugation and deficiency in autophagosome formationJoseph G Moloughney, Claude E Monken, Hanlin Tao, et al.
The Journal of Biological Chemistry|September 12, 2018
mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvationJoseph G Moloughney, Nicole M Vega-Cotto, Sharon Liu, et al.
Molecular Cell|August 30, 2016
mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1Joseph G Moloughney, Peter K Kim, Nicole M Vega-Cotto, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Recent Patents on Biotechnology|October 25, 2012
Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applicationsJoseph G Moloughney, Noah Weisleder
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Metallo-beta-lactamase inhibitors: promise for the future?Jeffrey H Toney, Joseph G Moloughney
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Old drugs resurrected?Janice D Thomas, Joseph G Moloughney, Jeffrey H Toney
FEMS Microbiology Letters|January 26, 2005
Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1Joseph G Moloughney, Janice D Thomas, Jeffrey H Toney
Plos One|November 28, 2012
Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscleXiaoli Zhao, Joseph G Moloughney, Sai Zhang, et al.
Autophagy|October 26, 2011
Vaccinia virus leads to ATG12–ATG3 conjugation and deficiency in autophagosome formationJoseph G Moloughney, Claude E Monken, Hanlin Tao, et al.
The Journal of Biological Chemistry|September 12, 2018
mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvationJoseph G Moloughney, Nicole M Vega-Cotto, Sharon Liu, et al.
Molecular Cell|August 30, 2016
mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1Joseph G Moloughney, Peter K Kim, Nicole M Vega-Cotto, et al.
Pageof 1